← Insider Monitor
ABEONA THERAPEUTICS INC. logo
ABEO

ABEONA THERAPEUTICS INC.

Nasdaq · Pharmaceutical Preparations

4
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Abeona Therapeutics develops gene and cell therapies for severe genetic and rare diseases, including skin and eye disorders, using its proprietary AAV-based gene therapy delivery platforms.

Industry
Pharmaceutical Preparations
Headquarters
Cleveland, OH
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Seshadri VishwasChief Executive OfficerSell$101KSep 29, 2026
Vazzano Joseph WalterChief Financial OfficerSell$47KSep 29, 2026
O'Malley Brendan M.SVP, Chief Legal OfficerSell$35KSep 29, 2026
Vasanthavada MadhavChief Commercial OfficerSell$25KSep 29, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for ABEO.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable ABEO activity by email

Free alerts for the insider and congressional trades worth watching.

Leave mobile blank for email only. Outside US/Canada, include + and your country code.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.